Pitavastatin and Atorvastatin double-blind randomized comPArative study among hiGh-risk patients, including thOse with Type 2 diabetes mellitus, in Taiwan (PAPAGO-T Study).

Pitavastatin and Atorvastatin double-blind randomized comPArative study among hiGh-risk patients, including thOse with Type 2 diabetes mellitus, in Taiwan (PAPAGO-T Study).

Evidence about the efficacy and safety of statin treatment in high-risk patients with hypercholesterolemia is available for some populations, but not for ethnic Chinese. To test the hypothesis that treatment with pitavastatin (2 mg/day) is not inferior to treatment with atorvastatin (10 mg/day) for...

Full description

Bibliographic Details
Main Authors: Ping-Yen Liu, Liang-Yu Lin, Hung-Ju Lin, Chien-Hsun Hsia, Yi-Ren Hung, Hung-I Yeh, Tao-Cheng Wu, Ju-Yi Chen, Kuo-Liong Chien, Jaw-Wen Chen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3788128?pdf=render

Internet

http://europepmc.org/articles/PMC3788128?pdf=render

Similar Items